Inventaire - your friends and communities are your best library

Cites articles 32

Date

Title

Authors

2009-12-21

Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors

Hagop Kantarjian, Stefan Faderl, Stephen H Petersdorf, Harry P Erba, Martha Arellano, Paul J Shami, Dan Douer, Janice Gabrilove
2009-12-21

Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia

Eva Hellström-Lindberg, Pierre Fenaux, Hervé Dombret, Ulrich Germing, Norbert Gattermann, Guillermo F Sanz, Valeria Santini, Alan F List, Jay Backstrom, Lewis B Silverman
2009-12-21

Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia

Amanda Cashen
2009-10-11

Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia

Frederick R. Appelbaum, Thomas R Chauncey, Cheryl L. Willman, Alan F List, Holly Gundacker, Marilyn L Slovak, Harry P Erba, Shaker R Dakhil
2009-09-01

High-dose daunorubicin in older patients with acute myeloid leukemia

Gregor Verhoef, Hartmut Döhner, Bob Löwenberg, Pieter Sonneveld, Alois Gratwohl, Johan Maertens, Harry Schouten
2009-06-15

Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial

Hagop Kantarjian, Guillermo Garcia-Manero, Maher Albitar, Lucy A Godley, David P. Steensma, Rena Buckstein
2009-03

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Pierre Fenaux, Eva Hellström-Lindberg, Valeria Santini, Guillermo F Sanz, Alan F List, John C Byrd, Aristoteles A N Giagounidis, Norbert Gattermann, Jay Backstrom, Lewis B Silverman
2009-02-11

MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.

Elisa Callegari, Lai-Chu Wu, Stefano Volinia, Carlo Maria Croce, Guido Marcucci, Clara D. Bloomfield, Michael Andreeff, Muller Fabbri, John C Byrd, Ramiro Garzon, William G Blum, Shujun Liu, Jiuxia Pang, Natarajan Muthusamy, Sebastian Schwind, Violaine Havelange, Danilo Perrotti
2009-12-21

"I am older, not elderly," said the patient with acute myeloid leukemia
2009-03-26

Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials

Anthony H. Goldstone
2009-03-01

Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7.

Meinolf Suttorp
2009-05-21

A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older.

Giovanni Martinelli, Hervé Dombret, Wiesław Jędrzejczak, Tadeusz Robak
2008-06-18

A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome

Hagop Kantarjian, Alessandra Ferrajoli, Stefan Faderl, Zeev Estrov, Srdan Verstovsek, Farhad Ravandi, Gautam Borthakur, Guillermo Garcia-Manero, Xuelin Huang, Monica Kwari
2007-10-02

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

Hansjuerg Alder, Stefano Volinia, Amelia Cimmino, Elisa Callegari, Carlo Maria Croce, Guido Marcucci, George A. Calin, Muller Fabbri
2007-08-06

Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia

Guido Marcucci, John C Byrd, Nyla A Heerema, Christoph Plass, Rebecca B Klisovic, Michael R Grever, William G Blum, Shujun Liu, Lenguyen Huynh, Steven M Devine, Hollie Devine, Cheryl Kefauver, Tamara Vukosavljevic, Gerard Lozanski
2007-02-01

The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia

Srdan Verstovsek, Maher Albitar
2007-03-01

A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment

Robert K Hills, Anthony H. Goldstone
2007-08-01

Preferential cytogenetic response to continuous intravenous low-dose decitabine (DAC) administration in myelodysplastic syndrome with monosomy 7
2006-08-01

Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia

Hagop Kantarjian, Stefan Faderl, Zeev Estrov, Srdan Verstovsek, William G Wierda, Jorge Eduardo Cortes, Elias Jabbour, Farhad Ravandi, Guillermo Garcia-Manero, Susan O'Brien, Jean-Pierre J Issa, Lianchun Xiao, Carlos B Bueso-Ramos, Michael E Rytting, Elihu Estey, Gary L Rosner, Jackie Fiorentino
2006-08-01

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia

Hagop Kantarjian, Alessandra Ferrajoli, Stefan Faderl, Zeev Estrov, William G Wierda, Jorge Eduardo Cortes, Susan O'Brien, Farhad Ravandi, Francis Giles, Guillermo Garcia-Manero, Jean-Pierre J Issa, Xuelin Huang, Carlos B Bueso-Ramos, Jianqin Shan, Yasuhiro Oki, Saba Hussain
2006-04-15

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

Hagop Kantarjian, Farhad Ravandi, Maher Albitar, Jean-Pierre J Issa, Saba Hussain, Virginia M Klimek, John DiPersio, Craig S Rosenfeld, Azra Raza, James Richard Slack, Lanlan Shen, Stephen D Nimer, Richard D Leavitt
2006-03-07

Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461

Kellie J Archer, Mazin Qumsiyeh, Richard A. Larson, James W Vardiman, Clara D. Bloomfield, Krzysztof Mrózek
2006-02-02

Age and acute myeloid leukemia

Frederick R. Appelbaum, Stephen H Petersdorf, Cheryl L. Willman, Holly Gundacker, Marilyn L Slovak, John Godwin
2006-06-01

Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms

Stephen B. Baylin
2005-02-01

Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia.

Guido Marcucci, John C Byrd, Christoph Plass, Shujun Liu, Lenguyen Huynh, Danilo Perrotti, Tamara Vukosavljevic, Brian Becknell, Marko I Klisovic, Tiansheng Shen
2003-12-01

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

Clara D. Bloomfield, Martin S. Tallman, Francesco Lo-Coco, Bob Löwenberg, Richard A. Larson, Cheryl L. Willman, Elihu Estey, Bruce D. Cheson
2003-11-20

Gene silencing in cancer in association with promoter hypermethylation
2003-02-01

Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells

Kellie J Archer
2003-11-06

Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies

Hagop Kantarjian, Stefan Faderl, Jorge Eduardo Cortes, Guillermo Garcia-Manero, Jean-Pierre J Issa, Francis J Giles, Craig S Rosenfeld
2002-05-01

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

Richard A. Larson, Jimmie C. Holland, John A. Ellerton
1999-01

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

Kurt Bachman
1987-08-01

Hypermethylation of the 5' region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies

Bert Vogelstein

Article - wd:Q33841988

Welcome to Inventaire

the library of your friends and communities

learn more

Article

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine

Cites articles 32

Welcome to Inventaire